HeimAZN • STO
add
AstraZeneca plc
Við síðustu lokun
1.465,00 kr.
Dagbil
1.445,00 kr. - 1.464,00 kr.
Árabil
1.261,00 kr. - 1.799,00 kr.
Markaðsvirði
160,40 ma. GBP
Meðalmagn
419,87 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
LON
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(USD) | sep. 2024info | Breyting á/á |
---|---|---|
Tekjur | 13,56 ma. | 18,04% |
Rekstrarkostnaður | 7,79 ma. | 4,64% |
Nettótekjur | 1,43 ma. | 4,00% |
Hagnaðarhlutfall | 10,53 | -11,96% |
Hagnaður á hvern hlut | 1,04 | 20,23% |
EBITDA | 4,63 ma. | 45,69% |
Virkt skatthlutfall | 21,61% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(USD) | sep. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 4,93 ma. | -3,62% |
Heildareignir | 104,92 ma. | 9,20% |
Heildarskuldir | 64,12 ma. | 8,92% |
Eigið fé alls | 40,80 ma. | — |
Útistandandi hlutabréf | 1,55 ma. | — |
Eiginfjárgengi | 55,77 | — |
Arðsemi eigna | 7,92% | — |
Ávöxtun eigin fjár | 11,38% | — |
Peningaflæði
Breyting á handbæru fé
(USD) | sep. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 1,43 ma. | 4,00% |
Handbært fé frá rekstri | 3,38 ma. | 8,64% |
Reiðufé frá fjárfestingum | -1,51 ma. | -24,00% |
Reiðufé frá fjármögnun | -4,13 ma. | -51,54% |
Breyting á handbæru fé | -2,24 ma. | -163,15% |
Frjálst peningaflæði | 2,05 ma. | -12,38% |
Um
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, United Kingdom. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, United Kingdom; Gothenburg, Sweden and Gaithersburg in Maryland, U.S.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Throughout the twentieth century, it grew into the largest pharmaceutical company in Sweden. Wikipedia
Framkvæmdastjóri
Stofnsett
6. apr. 1999
Höfuðstöðvar
Vefsvæði
Starfsfólk
89.900